The Pentagon has directed mandatory testosterone deficiency screening for all active-duty and reserve service members aged 30 and above, as part of the Trump administration's push to sharpen military readiness and address what it calls 'Operator Syndrome'. The policy, announced on Wednesday by Chief Pentagon Spokesman Sean Parnell, takes effect immediately.

What the New Directive Requires

Under the order signed by Defence Secretary Pete Hegseth, testosterone deficiency screening will become a mandatory element of the Periodic Health Assessment (PHA) for all personnel aged 30 and older. Service members below that age may request the screening voluntarily during their own PHA cycle.

Parnell stated the protocol is designed 'to optimise performance, combat Operator Syndrome, and maximise mission readiness.' The directive also authorises targeted testosterone therapy for those found deficient, with the stated aim of sustaining 'a healthy, capable, and decisively dominant fighting force.'

What Is 'Operator Syndrome'

The Pentagon has not released a standalone clinical definition of Operator Syndrome in this directive, but the term has previously been used within special operations medicine to describe a cluster of physical and hormonal issues — including testosterone deficiency — linked to the cumulative stress of high-tempo combat deployments. The new policy explicitly draws on 'lessons learned from treating Operator Syndrome across the Total Force.'

Implementation Timeline and Responsibilities

The Under Secretary of War for Personnel and Readiness has been instructed to update departmental policy by 15 August to incorporate the new requirement into existing health assessment guidance. The Military Departments and the Defence Health Agency must also align internal procedures and train medical personnel on the rollout.

The Assistant Secretary of War for Health Affairs will ensure testing availability across the Military Health System and will establish an advisory council of external experts to guide the Department's broader Health and Human Performance Optimisation effort.

Broader Warfighter Performance Push

The directive builds on a May memorandum from Hegseth that launched the Pentagon's 'Warfighter Performance Optimisation – Total Force Fitness' initiative. That document called for treating the warfighter 'as a readiness capability, held to the same disciplined evaluation, maintenance, and optimisation we demand of every asset that preserves combat power.' It also called for greater use of data analytics, wearable technologies, and cognitive performance measures to improve readiness across the force.

The testosterone screening mandate represents the most concrete clinical step yet under that framework, signalling a shift toward biomarker-based readiness assessment in the US military.